Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Insmed Inc (NASDAQ: INSM) was $196.55 for the day, down -3.65% from the previous closing price of $204.0. In other words, the price has decreased by -$3.65 from its previous closing price. On the day, 3.5 million shares were traded. INSM stock price reached its highest trading level at $206.69 during the session, while it also had its lowest trading level at $195.5394.
Ratios:
Our analysis of INSM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.34 and its Current Ratio is at 4.63. In the meantime, Its Debt-to-Equity ratio is 0.79 whereas as Long-Term Debt/Eq ratio is at 0.77.
Upgrades & Downgrades
In the most recent recommendation for this company, Rothschild & Co Redburn on December 04, 2025, initiated with a Buy rating and assigned the stock a target price of $263.
On October 20, 2025, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $171.Wells Fargo initiated its Overweight rating on October 20, 2025, with a $171 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 05 ’25 when MELVIN SHAROKY bought 20,000 shares for $205.00 per share.
Lewis William sold 10,699 shares of INSM for $2,199,915 on Dec 04 ’25. The Chair and CEO now owns 303,911 shares after completing the transaction at $205.62 per share. On Dec 04 ’25, another insider, William Lewis, who serves as the Officer of the company, bought 10,699 shares for $205.59 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSM now has a Market Capitalization of 41918902272 and an Enterprise Value of 40979050496. For the stock, the TTM Price-to-Sale (P/S) ratio is 93.77 while its Price-to-Book (P/B) ratio in mrq is 44.19. Its current Enterprise Value per Revenue stands at 91.671 whereas that against EBITDA is -41.867.
Stock Price History:
The Beta on a monthly basis for INSM is 1.07, which has changed by 1.8091435 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, INSM has reached a high of $212.75, while it has fallen to a 52-week low of $60.40. The 50-Day Moving Average of the stock is 8.97%, while the 200-Day Moving Average is calculated to be 68.55%.
Shares Statistics:
INSM traded an average of 2.30M shares per day over the past three months and 3345020 shares per day over the past ten days. A total of 212.58M shares are outstanding, with a floating share count of 210.31M. Insiders hold about 1.39% of the company’s shares, while institutions hold 100.26% stake in the company. Shares short for INSM as of 1763078400 were 8927374 with a Short Ratio of 3.88, compared to 1760486400 on 9481459. Therefore, it implies a Short% of Shares Outstanding of 8927374 and a Short% of Float of 4.63.
Earnings Estimates
The stock of Insmed Inc (INSM) is currently drawing attention from 12.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$1.32, with high estimates of -$0.88 and low estimates of -$1.63.
Analysts are recommending an EPS of between -$4.97 and -$6.92 for the fiscal current year, implying an average EPS of -$6.16. EPS for the following year is -$3.63, with 13.0 analysts recommending between -$2.07 and -$5.36.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 16 analysts. It ranges from a high estimate of $197.9M to a low estimate of $148M. As of. The current estimate, Insmed Inc’s year-ago sales were $104.44MFor the next quarter, 16 analysts are estimating revenue of $194.78M. There is a high estimate of $231M for the next quarter, whereas the lowest estimate is $170M.
A total of 18 analysts have provided revenue estimates for INSM’s current fiscal year. The highest revenue estimate was $540.48M, while the lowest revenue estimate was $470M, resulting in an average revenue estimate of $512.67M. In the same quarter a year ago, actual revenue was $363.71MBased on 17 analysts’ estimates, the company’s revenue will be $1.22B in the next fiscal year. The high estimate is $1.49B and the low estimate is $1.03B.
